Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis.
about
Incidence and Reproduction Numbers of Pertussis: Estimates from Serological and Social Contact Data in Five European CountriesSpecific antibodies against vaccine-preventable infections: a mother-infant cohort studyIncreased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in AustraliaA cocktail of humanized anti-pertussis toxin antibodies limits disease in murine and baboon models of whooping cough.Impact of age and vaccination history on long-term serological responses after symptomatic B. pertussis infection, a high dimensional data analysisUtilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: meeting at the crossroadsAcellular pertussis vaccines and the role of pertactin and fimbriae.Pertussis-specific memory B-cell and humoral IgG responses in adolescents after a fifth consecutive dose of acellular pertussis vaccineResurgence of pertussis calls for re-evaluation of pertussis animal models.Resolving pertussis immunity and vaccine effectiveness using incidence time series.Pertussis vaccine: a critique.Pertussis vaccination for adolescents and adults.Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway.Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program.Is there a need for a new generation of vaccines against pertussis?Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative studyComparisons of the effect of naturally acquired maternal pertussis antibodies and antenatal vaccination induced maternal tetanus antibodies on infant's antibody secreting lymphocyte responses and circulating plasma antibody levels.Synergistic Neutralization of Pertussis Toxin by a Bispecific Antibody In Vitro and In VivoThe Effect of Maternal Pertussis Immunization on Infant Vaccine Responses to a Booster Pertussis-Containing Vaccine in Vietnam.Age related differences in dynamics of specific memory B cell populations after clinical pertussis infection.Prior exposure to Bordetella species as an exclusion criterion in the baboon model of pertussis.Toward a new vaccine for pertussisCorrelates of protection induced by vaccination.Pertussis: a matter of immune modulation.Complex correlates of protection after vaccination.Immune persistence after pertussis vaccination.Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis.Determining best strategies for maternally-targeted pertussis vaccination using an individual-based model.A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers.Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
P2860
Q27681116-90D2AB71-E637-4654-9CD9-FC4447C352ADQ28706294-35D79F18-7EDB-420F-966F-4F0A624A086DQ28730264-207C72C3-064E-42E2-BAD1-46004CC78E1FQ30825645-5DE3DBEF-4788-4437-B535-A8FF381EE54CQ31154853-39757691-FFC2-4D09-AC04-07685105177EQ33916408-03F21D27-1B77-4996-A536-C61BC7B16E26Q34002283-8CFA08DE-A2F2-4649-A7B6-03AFFF838566Q34260834-BF632CA3-55BD-4AD9-BE39-1501DBD7C641Q34311615-D4BCD9A2-78E0-4F1F-ABA9-0018B4B1B409Q34318319-32F089C1-2871-41BA-9F1E-D93041F9484BQ34657980-9911E1F7-8FDD-42BF-97EE-C28B0FAE1AFAQ35907047-8B3BE647-CA86-4CA2-989A-93514631C7E5Q35946858-6F29A5F0-6E3E-4E01-AAE5-F1CE92F40458Q36189916-6B32DAD8-091D-4F02-9A42-A3337B03811FQ36458388-A83D17E5-B88E-4695-B4C9-1C4EFC50985EQ37116561-39EEC4C4-5E97-4DDB-A733-478B99B1FBC4Q37130723-6AE73229-6FB9-46F8-BD04-6859B536B355Q37396968-2D3FFD21-1F6E-48BF-99E4-10E3C1D45D79Q37410323-9827C247-21E1-42EE-ADEB-E26E2C69BE31Q37472929-19F6ED51-F5D9-4DCA-A406-FF28C3FD3D7BQ37621323-30D2E8EC-9B58-4426-925A-1434FDE07746Q37628007-BBC1BEF8-B102-45EB-B370-791EE67690EFQ37750121-63594033-9C07-492B-A6E3-221855E46818Q37825920-722734C6-E8D9-4980-9B90-9BBCE0016BF9Q38456515-841515A1-8E90-45AB-9C97-79F68428B8FAQ38775297-C2CBCD67-94D2-4D4F-B0E4-F596389EC52EQ39704880-62450019-A4E8-4D9C-BA3F-4B65B8A410C9Q40233758-0E4116EA-ADDE-4EE0-A131-2F882C46758AQ41860045-42BA64BE-BEAF-4C48-BA04-BFBACBA92C10Q52558356-DF066217-1162-45F3-82E7-0A3166685229
P2860
Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Low levels of antipertussis an ...... osure to Bordetella pertussis.
@en
Low levels of antipertussis an ...... osure to Bordetella pertussis.
@nl
type
label
Low levels of antipertussis an ...... osure to Bordetella pertussis.
@en
Low levels of antipertussis an ...... osure to Bordetella pertussis.
@nl
prefLabel
Low levels of antipertussis an ...... osure to Bordetella pertussis.
@en
Low levels of antipertussis an ...... osure to Bordetella pertussis.
@nl
P2093
P1433
P1476
Low levels of antipertussis an ...... osure to Bordetella pertussis.
@en
P2093
Hans O Hallander
Jann Storsaeter
Lennart Gustafsson
Patrick Olin
P304
P356
10.1016/S0264-410X(03)00407-9
P407
P577
2003-09-01T00:00:00Z